Rail-Splitter Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rail-Splitter Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-160,229	Closed	-$3.64M	–	49
2016 Q3	$3.64M	Sell	160,229 -61,185	-28%	-$1.44M	1.02%	32
2016 Q2	$5.22M	Buy	+221,414	New	+$5.47M	1.25%	35
2014 Q2	–	Sell	-90,680	Closed	-$2.35M	–	49
2014 Q1	$2.35M	Buy	+90,680	New	+$2.42M	0.78%	39

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rail-Splitter Capital Management's PTLA Position: Q4 2016 in Review

Rail-Splitter Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2016, closing a stake of 160,229 shares — an estimated $3.64M sold.

Rail-Splitter Capital Management first reported a position in PTLA in Q1 2014 and held it in 3 quarters. The position peaked at $5.22M in Q2 2016. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

Rail-Splitter Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Rail-Splitter Capital Management sold 160,229 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $3.64M.
Rail-Splitter Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Rail-Splitter Capital Management's Portola Pharmaceuticals, Inc. position peaked at $5.22M in Q2 2016.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on Rail-Splitter Capital Management's 13F filing for Q4 2016, filed 8 Feb 2017.